COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1Life Healthcare, Inc. | Common | 68269G107 | 522,455 | 31,266 | SH | | SOLE | | 522,455 | 0 | 0 |
Abbott Laboratories | Common | 002824100 | 76,090,069 | 693,051 | SH | | SOLE | | 76,090,069 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 77,304,851 | 478,342 | SH | | SOLE | | 77,304,851 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 11,622,678 | 141,189 | SH | | SOLE | | 11,622,678 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 1,149,822 | 72,225 | SH | | SOLE | | 1,149,822 | 0 | 0 |
Adaptive Biotechnologies Corp. | Common | 00650F109 | 3,226,227 | 422,281 | SH | | SOLE | | 3,226,227 | 0 | 0 |
Addus HomeCare Corp. | Common | 006739106 | 4,216,386 | 42,380 | SH | | SOLE | | 4,216,386 | 0 | 0 |
Adicet Bio, Inc. | Common | 007002108 | 360,541 | 40,329 | SH | | SOLE | | 360,541 | 0 | 0 |
Affimed N.V. | Common | N01045108 | 726,687 | 586,038 | SH | | SOLE | | 726,687 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 6,463,533 | 43,191 | SH | | SOLE | | 6,463,533 | 0 | 0 |
AlerisLife Inc. | Common | 33832D205 | 13,330 | 24,237 | SH | | SOLE | | 13,330 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 10,718,782 | 50,824 | SH | | SOLE | | 10,718,782 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 8,090,188 | 309,613 | SH | | SOLE | | 8,090,188 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 7,560,151 | 428,580 | SH | | SOLE | | 7,560,151 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 34,034,807 | 143,214 | SH | | SOLE | | 34,034,807 | 0 | 0 |
ALX Oncology Holdings Inc. | Common | 00166B105 | 746,198 | 66,211 | SH | | SOLE | | 746,198 | 0 | 0 |
Amerisourcebergen Corp. | Common | 03073E105 | 3,383,301 | 20,417 | SH | | SOLE | | 3,383,301 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 133,598,665 | 508,676 | SH | | SOLE | | 133,598,665 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 3,434,888 | 66,426 | SH | | SOLE | | 3,434,888 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 76,608 | 32,461 | SH | | SOLE | | 76,608 | 0 | 0 |
Arcutis Biotherapeutics, Inc. | Common | 03969K108 | 2,203,335 | 148,874 | SH | | SOLE | | 2,203,335 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 1,537,313 | 539,408 | SH | | SOLE | | 1,537,313 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 31,829,675 | 84,021 | SH | | SOLE | | 31,829,675 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 4,073,116 | 100,422 | SH | | SOLE | | 4,073,116 | 0 | 0 |
Arvinas, Inc. | Common | 04335A105 | 1,470,962 | 42,998 | SH | | SOLE | | 1,470,962 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 15,118,595 | 123,791 | SH | | SOLE | | 15,118,595 | 0 | 0 |
Assertio Holdings, Inc. | Common | 04546C205 | 1,765,473 | 410,575 | SH | | SOLE | | 1,765,473 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 69,308,889 | 1,022,255 | SH | | SOLE | | 69,308,889 | 0 | 0 |
Avantor, Inc. | Common | 05352A100 | 9,690,602 | 459,488 | SH | | SOLE | | 9,690,602 | 0 | 0 |
Beam Therapeutics Inc. | Common | 07373V105 | 618,603 | 15,817 | SH | | SOLE | | 618,603 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 4,608,183 | 20,952 | SH | | SOLE | | 4,608,183 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 4,320 | 6,000 | SH | | SOLE | | 4,320 | 0 | 0 |
Bicycle Therapeutics PLC | Sponsored ADS | 088786108 | 2,624,810 | 88,676 | SH | | SOLE | | 2,624,810 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | Common | 09058V103 | 7,722,653 | 672,705 | SH | | SOLE | | 7,722,653 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 54,118,476 | 195,430 | SH | | SOLE | | 54,118,476 | 0 | 0 |
Biohaven Ltd. | Common | G1110E107 | 487,008 | 35,087 | SH | | SOLE | | 487,008 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 23,884,457 | 230,790 | SH | | SOLE | | 23,884,457 | 0 | 0 |
BioNTech SE | Sponsored ADS | 09075V102 | 15,601,549 | 103,858 | SH | | SOLE | | 15,601,549 | 0 | 0 |
Black Diamond Therapeutics, Inc. | Common | 09203E105 | 237,582 | 131,990 | SH | | SOLE | | 237,582 | 0 | 0 |
Blueprint Medicines Corp. | Common | 09627Y109 | 2,966,375 | 67,710 | SH | | SOLE | | 2,966,375 | 0 | 0 |
Boston Scientific Corp. | Common | 101137107 | 35,027,084 | 757,015 | SH | | SOLE | | 35,027,084 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 49,467,712 | 687,529 | SH | | SOLE | | 49,467,712 | 0 | 0 |
Cardiovascular Systems, Inc. | Common | 141619106 | 2,381,580 | 174,859 | SH | | SOLE | | 2,381,580 | 0 | 0 |
Caribou Biosciences, Inc. | Common | 142038108 | 3,561,683 | 567,147 | SH | | SOLE | | 3,561,683 | 0 | 0 |
Catalent, Inc. | Common | 148806102 | 5,668,874 | 125,947 | SH | | SOLE | | 5,668,874 | 0 | 0 |
Cerevel Therapeutics Holdings, Inc. | Common | 15678U128 | 5,566,274 | 176,483 | SH | | SOLE | | 5,566,274 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 15,835,883 | 72,675 | SH | | SOLE | | 15,835,883 | 0 | 0 |
Cigna Corp. | Common | 125523100 | 60,512,956 | 182,631 | SH | | SOLE | | 60,512,956 | 0 | 0 |
Codexis Inc | Common | 192005106 | 322,123 | 69,125 | SH | | SOLE | | 322,123 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 381,607 | 88,335 | SH | | SOLE | | 381,607 | 0 | 0 |
Community Healthcare Trust Inc. | Common | 20369C106 | 533,420 | 14,900 | SH | | SOLE | | 533,420 | 0 | 0 |
Corbus Pharmaceuticals Holdings, Inc. | Common | 21833P103 | 17,051 | 154,310 | SH | | SOLE | | 17,051 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | Common | 22663K107 | 839,256 | 45,861 | SH | | SOLE | | 839,256 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 2,239,002 | 55,080 | SH | | SOLE | | 2,239,002 | 0 | 0 |
CVS Health Corp. | Common | 126650100 | 8,724,541 | 93,621 | SH | | SOLE | | 8,724,541 | 0 | 0 |
Cytokinetics, Inc. | Common | 23282W605 | 3,442,869 | 75,139 | SH | | SOLE | | 3,442,869 | 0 | 0 |
Danaher Corp. | Common | 235851102 | 28,052,240 | 105,690 | SH | | SOLE | | 28,052,240 | 0 | 0 |
Denali Therapeutics, Inc. | Common | 24823R105 | 7,578,781 | 272,520 | SH | | SOLE | | 7,578,781 | 0 | 0 |
Dexcom, Inc. | Common | 252131107 | 24,688,019 | 218,015 | SH | | SOLE | | 24,688,019 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 231,373 | 357,720 | SH | | SOLE | | 231,373 | 0 | 0 |
Edgewise Therapeutics, Inc. | Common | 28036F105 | 1,743,524 | 195,025 | SH | | SOLE | | 1,743,524 | 0 | 0 |
Edwards Lifesciences Corp. | Common | 28176E108 | 12,787,259 | 171,388 | SH | | SOLE | | 12,787,259 | 0 | 0 |
Elevance Health, Inc. | Common | 036752103 | 7,511,933 | 14,644 | SH | | SOLE | | 7,511,933 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 105,697,395 | 288,917 | SH | | SOLE | | 105,697,395 | 0 | 0 |
Fulcrum Therapeutics, Inc. | Common | 359616109 | 426,149 | 58,537 | SH | | SOLE | | 426,149 | 0 | 0 |
Fusion Pharmaceuticals Inc. | Common | 36118A100 | 136,691 | 43,394 | SH | | SOLE | | 136,691 | 0 | 0 |
G1 Therapeutics, Inc. | Common | 3621LQ109 | 2,301,609 | 423,869 | SH | | SOLE | | 2,301,609 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 1,338,577 | 898,374 | SH | | SOLE | | 1,338,577 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 129,671,274 | 1,510,440 | SH | | SOLE | | 129,671,274 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,658,024 | 174,897 | SH | | SOLE | | 1,658,024 | 0 | 0 |
GSK plc ADR | Sponsored ADR | 37733W204 | 1,470,679 | 41,852 | SH | | SOLE | | 1,470,679 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 12,843,405 | 472,184 | SH | | SOLE | | 12,843,405 | 0 | 0 |
Harpoon Therapeutics, Inc. | Common | 41358P106 | 188,617 | 259,910 | SH | | SOLE | | 188,617 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 25,196,520 | 105,003 | SH | | SOLE | | 25,196,520 | 0 | 0 |
Healthcare Realty Trust Inc. | Common | 42226K105 | 3,366,199 | 174,686 | SH | | SOLE | | 3,366,199 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 6,793,591 | 110,214 | SH | | SOLE | | 6,793,591 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,770,327 | 150,392 | SH | | SOLE | | 3,770,327 | 0 | 0 |
Horizon Therapeutics plc | Common | G46188101 | 47,233,031 | 415,053 | SH | | SOLE | | 47,233,031 | 0 | 0 |
Humana Inc. | Common | 444859102 | 39,803,821 | 77,713 | SH | | SOLE | | 39,803,821 | 0 | 0 |
I-Mab | Sponsored ADS | 44975P103 | 679,584 | 162,580 | SH | | SOLE | | 679,584 | 0 | 0 |
Icon plc | Shares | G4705A100 | 1,813,130 | 9,334 | SH | | SOLE | | 1,813,130 | 0 | 0 |
IDEAYA Biosciences, Inc. | Common | 45166A102 | 2,419,971 | 133,185 | SH | | SOLE | | 2,419,971 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 27,767,797 | 68,065 | SH | | SOLE | | 27,767,797 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 64,695,508 | 319,958 | SH | | SOLE | | 64,695,508 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 5,382,445 | 154,269 | SH | | SOLE | | 5,382,445 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 644,069 | 52,067 | SH | | SOLE | | 644,069 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 9,121,873 | 172,371 | SH | | SOLE | | 9,121,873 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 29,899,638 | 112,680 | SH | | SOLE | | 29,899,638 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 3,317,717 | 87,840 | SH | | SOLE | | 3,317,717 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 12,932,042 | 63,117 | SH | | SOLE | | 12,932,042 | 0 | 0 |
Ishares Biothechnology ETF | Common | 464287556 | 3,225,664 | 24,569 | SH | | SOLE | | 3,225,664 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 29,119,000 | 182,782 | SH | | SOLE | | 29,119,000 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 112,999,295 | 639,679 | SH | | SOLE | | 112,999,295 | 0 | 0 |
Karuna Therapeutics, Inc. | Common | 48576A100 | 10,503,318 | 53,452 | SH | | SOLE | | 10,503,318 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Shares | 500472303 | 1,646,801 | 109,860 | SH | | SOLE | | 1,646,801 | 0 | 0 |
Kura Oncology, Inc. | Common | 50127T109 | 3,515,517 | 283,281 | SH | | SOLE | | 3,515,517 | 0 | 0 |
Laboratory Corporation of America Holdings | Common | 50540R409 | 10,394,558 | 44,142 | SH | | SOLE | | 10,394,558 | 0 | 0 |
Lantheus Holdings, Inc. | Common | 516544103 | 17,472,757 | 342,872 | SH | | SOLE | | 17,472,757 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,476,870 | 182,293 | SH | | SOLE | | 6,476,870 | 0 | 0 |
Mallinckrodt plc | Shares | G5890A102 | 271,622 | 35,048 | SH | | SOLE | | 271,622 | 0 | 0 |
McKesson Corp. | Common | 58155Q103 | 24,928,600 | 66,455 | SH | | SOLE | | 24,928,600 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 4,586,817 | 411,743 | SH | | SOLE | | 4,586,817 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 2,004,088 | 9,435 | SH | | SOLE | | 2,004,088 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 25,350,088 | 326,172 | SH | | SOLE | | 25,350,088 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 61,257,936 | 552,122 | SH | | SOLE | | 61,257,936 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 1,163,312 | 1,551,082 | SH | | SOLE | | 1,163,312 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 1,428,268 | 92,325 | SH | | SOLE | | 1,428,268 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 2,967,352 | 65,490 | SH | | SOLE | | 2,967,352 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 47,586,188 | 264,927 | SH | | SOLE | | 47,586,188 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 24,309,145 | 73,615 | SH | | SOLE | | 24,309,145 | 0 | 0 |
MoonLake Immunotherapeutics AG | Common | 61559X104 | 3,150,000 | 300,000 | SH | | SOLE | | 3,150,000 | 0 | 0 |
Morphic Holding, Inc. | Common | 61775R105 | 1,193,719 | 44,625 | SH | | SOLE | | 1,193,719 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 293,084 | 81,867 | SH | | SOLE | | 293,084 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 1,979,256 | 49,272 | SH | | SOLE | | 1,979,256 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 524,184 | 10,038 | SH | | SOLE | | 524,184 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 13,485,732 | 112,908 | SH | | SOLE | | 13,485,732 | 0 | 0 |
NexGel, Inc. | Common | 65344E107 | 5,304 | 4,243 | SH | | SOLE | | 5,304 | 0 | 0 |
Nkarta, Inc. | Common | 65487U108 | 173,638 | 28,988 | SH | | SOLE | | 173,638 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 12,358,332 | 136,225 | SH | | SOLE | | 12,358,332 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 655,864 | 63,800 | SH | | SOLE | | 655,864 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 17,664,983 | 130,523 | SH | | SOLE | | 17,664,983 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 8,564,802 | 306,433 | SH | | SOLE | | 8,564,802 | 0 | 0 |
Option Care Health, Inc. | Common | 68404L201 | 1,955,098 | 64,975 | SH | | SOLE | | 1,955,098 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 1,746,226 | 51,224 | SH | | SOLE | | 1,746,226 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 74,665,391 | 1,457,170 | SH | | SOLE | | 74,665,391 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 2,441,682 | 168,741 | SH | | SOLE | | 2,441,682 | 0 | 0 |
Pliant Therapeutics, Inc. | Common | 729139105 | 681,054 | 35,233 | SH | | SOLE | | 681,054 | 0 | 0 |
Praxis Precision Medicines, Inc. | Common | 74006W108 | 178,500 | 75,000 | SH | | SOLE | | 178,500 | 0 | 0 |
Precision BioSciences, Inc. | Common | 74019P108 | 267,195 | 224,534 | SH | | SOLE | | 267,195 | 0 | 0 |
Prometheus Biosciences, Inc. | Common | 74349U108 | 4,206,070 | 38,237 | SH | | SOLE | | 4,206,070 | 0 | 0 |
Protagonist Therapeutics, Inc. | Common | 74366E102 | 1,333,977 | 122,271 | SH | | SOLE | | 1,333,977 | 0 | 0 |
Pyxis Oncology, Inc. | Common | 747324101 | 949,126 | 708,303 | SH | | SOLE | | 949,126 | 0 | 0 |
R1 RCM Inc. | Common | 77634L105 | 2,215,743 | 202,351 | SH | | SOLE | | 2,215,743 | 0 | 0 |
Rallybio Corporation | Common | 75120L100 | 11,346,830 | 1,727,067 | SH | | SOLE | | 11,346,830 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 87,200,724 | 120,862 | SH | | SOLE | | 87,200,724 | 0 | 0 |
Repare Therapeutics Inc. | Common | 760273102 | 428,797 | 29,150 | SH | | SOLE | | 428,797 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 12,633,283 | 60,699 | SH | | SOLE | | 12,633,283 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 6,347,504 | 510,660 | SH | | SOLE | | 6,347,504 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 5,978,877 | 123,454 | SH | | SOLE | | 5,978,877 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 18,265,467 | 140,959 | SH | | SOLE | | 18,265,467 | 0 | 0 |
Scholar Rock Holding Corp. | Common | 80706P103 | 984,939 | 108,833 | SH | | SOLE | | 984,939 | 0 | 0 |
Seagen Inc. | Common | 81181C104 | 14,420,621 | 112,214 | SH | | SOLE | | 14,420,621 | 0 | 0 |
Smith & Nephew plc | Sponsored ADR | 83175M205 | 4,886,182 | 181,710 | SH | | SOLE | | 4,886,182 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 12,257,191 | 147,677 | SH | | SOLE | | 12,257,191 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 42,256 | 114,670 | SH | | SOLE | | 42,256 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 3,078,598 | 16,669 | SH | | SOLE | | 3,078,598 | 0 | 0 |
Stevanato Group Societa' Per Azioni | Ordinary Shares | T9224W109 | 1,279,284 | 71,190 | SH | | SOLE | | 1,279,284 | 0 | 0 |
Stryker Corp. | Common | 863667101 | 40,127,655 | 164,128 | SH | | SOLE | | 40,127,655 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 1,192,050 | 147,531 | SH | | SOLE | | 1,192,050 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,995,898 | 117,717 | SH | | SOLE | | 2,995,898 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 1,639,139 | 105,073 | SH | | SOLE | | 1,639,139 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 4,192,017 | 459,651 | SH | | SOLE | | 4,192,017 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 51,602,406 | 93,705 | SH | | SOLE | | 51,602,406 | 0 | 0 |
Theseus Pharmaceuticals, Inc. | Common | 88369M101 | 498,000 | 100,000 | SH | | SOLE | | 498,000 | 0 | 0 |
Travere Therapeutics, Inc. | Common | 89422G107 | 8,801,476 | 418,520 | SH | | SOLE | | 8,801,476 | 0 | 0 |
TScan Therapeutics, Inc. | Common | 89854M101 | 326,000 | 200,000 | SH | | SOLE | | 326,000 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 3,107,121 | 67,065 | SH | | SOLE | | 3,107,121 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 14,790,951 | 652,446 | SH | | SOLE | | 14,790,951 | 0 | 0 |
United Therapeutics Corp. | Common | 91307C102 | 32,001,763 | 115,077 | SH | | SOLE | | 32,001,763 | 0 | 0 |
Unitedhealth Group Inc. | Common | 91324P102 | 143,438,078 | 270,546 | SH | | SOLE | | 143,438,078 | 0 | 0 |
Universal Health Realty Income Trust | Common | 91359E105 | 537,344 | 11,258 | SH | | SOLE | | 537,344 | 0 | 0 |
Vaxcyte, Inc. | Common | 92243G108 | 239,750 | 5,000 | SH | | SOLE | | 239,750 | 0 | 0 |
VectivBio Holding AG | Common | H9060V101 | 6,351,631 | 737,704 | SH | | SOLE | | 6,351,631 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 3,003,979 | 66,681 | SH | | SOLE | | 3,003,979 | 0 | 0 |
Vertex Pharmaceuticals Inc. | Common | 92532F100 | 95,396,452 | 330,343 | SH | | SOLE | | 95,396,452 | 0 | 0 |
VYNE Therapeutics Inc. | Common | 92941V209 | 20,309 | 135,395 | SH | | SOLE | | 20,309 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 2,719,276 | 41,484 | SH | | SOLE | | 2,719,276 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 5,216,541 | 200,328 | SH | | SOLE | | 5,216,541 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 3,300,843 | 83,714 | SH | | SOLE | | 3,300,843 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 1,329,310 | 43,300 | SH | | SOLE | | 1,329,310 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 33,005,670 | 258,868 | SH | | SOLE | | 33,005,670 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 20,064,747 | 136,914 | SH | | SOLE | | 20,064,747 | 0 | 0 |